share_log

Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Canaccord Genuity 將T2 Biosystems的評級下調至持有,將目標股價調整至2.5美元
Benzinga Real-time News ·  2022/10/14 04:56

Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.

Canaccord Genuity分析師凱爾·米克森將T2 Biosystems(納斯達克股票代碼:TTOO)的評級從買入下調至持有,並將目標股價從12.5美元調整爲2.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論